Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients
This is a non-randomized, non-interventional pilot observational study designed to follow high-risk patients through their surgical and hospital stay. The investigators will collect 2 4ml vial's of blood (total of 8ml) prior to surgery to assess CV biomarkers - inflammatory, metabolic, hypercoagulable and platelet.
Checked against the public recordLast updated Nov 17, 2015 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- NYU Langone Health
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * • ≥ 21 years of age * Subjects undergoing open orthopedic surgery of the hip, knee or spine * High-risk subject cohort: * Coronary artery disease (CAD), or * Cerebrovascular disease (CVD) (prior stroke, TIA or carotid artery disease (\>70% stenosis), or * Peripheral artery disease (PAD), or * Age ≥ 60 years and any 2 of the following: * Renal insufficiency (creatinine clearance \< 60ml/min) * Diabetes * Chronic Obstructive Pulmonary Disease (COPD) * Hypertension * Active smoker or stopped less than 30 days prior to consent * Cancer * Congestive heart failure * Prior blood clot Exclusion Criteria: * • Severe co-morbid condition with life expectancy \< 6 months * Inability to give informed consent or adhere to follow-up as per protocol
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- NYU Hospital for Joint DiseasesNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 17, 2015. Always confirm current availability with the study team.